Opioid Damages and Health Care Costs Recovery Act, SBC 2018, c. 35
Section 3
Recovery of cost of health care benefits on aggregate basis
Cite as Opioid Damages and Health Care Costs Recovery Act, SBC 2018, c. 35, s. 3 · read from BC Laws on November 17, 2026
The text
(1) In an action under section 2 (1) or 2.1 (1) for the recovery of the cost of health care benefits on an aggregate basis, subsection (2) of this section applies if the government, or the government of Canada, as the case may be, proves, on a balance of probabilities, that, in respect of a type of opioid product,
(a) the defendant breached a common law, equitable or statutory duty or obligation owed to insured persons who have used or been exposed to or might use or be exposed to the type of opioid product,
(b) using the type of opioid product can cause or contribute to disease, injury or illness, and
(c) during all or part of the period of the breach referred to in paragraph (a) of this subsection, the type of opioid product, manufactured or promoted by the defendant, was offered for distribution or sale in British Columbia.
(2) Subject to subsections (1) and (4), the court must presume that
(a) the population of insured persons who used or were exposed to the type of opioid product manufactured or promoted by the defendant would not have used or been exposed to the product but for the breach referred to in subsection (1) (a), and
(b) the use or exposure described in paragraph (a) of this subsection caused or contributed to disease, injury or illness or the risk of disease, injury or illness in a portion of the population described in paragraph (a) of this subsection.
(3) If the presumptions under subsection (2) (a) and (b) apply,
(a) the court must determine on an aggregate basis the cost of health care benefits provided after the date of the breach referred to in subsection (1) (a) resulting from use or exposure to the type of opioid product, and
(b) each defendant to which the presumptions apply is liable for the proportion of the aggregate cost referred to in paragraph (a) of this subsection equal to its market share in the type of opioid product.
(4) The amount of a defendant's liability assessed under subsection (3) (b) may be reduced, or the proportions of liability assessed under subsection (3) (b) readjusted among the defendants, to the extent that a defendant proves, on a balance of probabilities, that the breach referred to in subsection (1) (a) did not cause or contribute to the use or exposure referred to in subsection (2) (a) or to the disease, injury or illness or risk of disease, injury or illness referred to in subsection (2) (b).
Read the Opioid Damages and Health Care Costs Recovery Act on BC Laws ↗